RE: Radio 4: Inside Science16 Sep 2021 17:58
From SCLP RNS 24/4/20:
Professor Jonathan Ball, Director of the Centre for Research on Global Virus Infections at the University
of Nottingham added:
“Focusing the antibody responses on the receptor binding domain of the SARS-CoV-2 virus should
ensure the generation of high-titre antibodies that prevent infection. Delivering these virus targets using
Scancell’s DNA vaccine platform, which has already been shown to be safe and effe